2.56 USD
+0.16 (+6.67%)
2.5291 USD
-0.03 (-1.21%)
Taking everything into account, MAIA scores 2 out of 10 in our fundamental rating. MAIA was compared to 525 industry peers in the Biotechnology industry. MAIA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MAIA has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- MAIA had negative earnings in the past year.
- In the past year MAIA has reported a negative cash flow from operations.
- In the past 5 years MAIA always reported negative net income.
- In the past 5 years MAIA always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of MAIA (-146.41%) is worse than 83.24% of its industry peers.
- With a Return On Equity value of -417.16%, MAIA is not doing good in the industry: 74.29% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -146.41% | ||
| ROE | -417.16% | ||
| ROIC | N/A |
ROA(3y)-208.41%
ROA(5y)-324.93%
ROE(3y)-1657.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- MAIA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for MAIA has been increased compared to 1 year ago.
- MAIA has more shares outstanding than it did 5 years ago.
- MAIA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- MAIA has an Altman-Z score of -10.13. This is a bad value and indicates that MAIA is not financially healthy and even has some risk of bankruptcy.
- MAIA's Altman-Z score of -10.13 is on the low side compared to the rest of the industry. MAIA is outperformed by 72.38% of its industry peers.
- There is no outstanding debt for MAIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -10.13 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- MAIA has a Current Ratio of 2.19. This indicates that MAIA is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of MAIA (2.19) is worse than 74.48% of its industry peers.
- A Quick Ratio of 2.19 indicates that MAIA has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 2.19, MAIA is doing worse than 71.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.19 | ||
| Quick Ratio | 2.19 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 46.72% over the past year.
EPS 1Y (TTM)46.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-145.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- MAIA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 106.17% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y30.75%
EPS Next 2Y16.37%
EPS Next 3Y114.3%
EPS Next 5Y106.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- MAIA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year MAIA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as MAIA's earnings are expected to grow with 114.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.37%
EPS Next 3Y114.3%
5. Dividend
5.1 Amount
- No dividends for MAIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
MAIA BIOTECHNOLOGY INC / MAIA FAQ
What is the fundamental rating for MAIA stock?
ChartMill assigns a fundamental rating of 2 / 10 to MAIA.
What is the valuation status for MAIA stock?
ChartMill assigns a valuation rating of 1 / 10 to MAIA BIOTECHNOLOGY INC (MAIA). This can be considered as Overvalued.
What is the profitability of MAIA stock?
MAIA BIOTECHNOLOGY INC (MAIA) has a profitability rating of 0 / 10.
Can you provide the financial health for MAIA stock?
The financial health rating of MAIA BIOTECHNOLOGY INC (MAIA) is 5 / 10.
What is the earnings growth outlook for MAIA BIOTECHNOLOGY INC?
The Earnings per Share (EPS) of MAIA BIOTECHNOLOGY INC (MAIA) is expected to grow by 30.75% in the next year.